Concepta PLC Concepta pre-launch myLotus in the UK
March 29 2018 - 1:02AM
RNS Non-Regulatory
TIDMCPT
Concepta PLC
29 March 2018
29 March 2018
Concepta plc
("Concepta" or the "Company")
Concepta pre-launch myLotus in the UK
Concepta plc (AIM: CPT) the UK healthcare company and developer
of a proprietary product targeted at the mobile health market with
a primary focus on women's fertility, is pleased to announce that
it showcased its myLotus products at the Manchester Fertility Show
on 24 and 25 March 2018.
Concepta announced the forthcoming launch of its myLotus
products in the UK at the event which was attended by 53
specialised fertility exhibitors and approximately 1,200 people
with fertility issues. The Company is currently in the final stages
of the CE-marking process for myLotus and the product is expected
to be available in the UK in H2 2018, once the final audit by the
British Standards Institution
("BSI") is complete.
The myLotus website www.mylotus.com is now live and the
Company's pre-launch digital marketing strategy has commenced. The
consumer twitter page for myLotus is now active at
www.twitter.com/myLotusMonitor.
Erik Henau, CEO of Concepta commented: "The event was a great
success and consumer feedback has been excellent, with many women
and fertility support groups registering to be kept updated on the
launch date of myLotus products in the UK.
"Having launched our myLotus website, our focus is now on
driving marketing and raising further awareness of Concepta and
myLotus products in our home market, in anticipation of its launch
in the latter half of the year."
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 1234 866601
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin / Mark Brady
Tel: +44 (0)20 368 3550
NOVUM Securities Limited (Broker)
Colin Rowbury
+44 (0) 20 7399 9400
Yellow Jersey (Financial PR)
Georgia Colkin / Joe Burgess / Katie Bairsto
Tel: +44 (0) 776 932 5254
Notes to Editors
Concepta Plc
Concepta plc is an AIM-quoted pioneering UK healthcare company
that has developed a proprietary product, myLotus, targeted at the
personalised mobile health market with a primary focus on
unexplained infertility in women.
myLotus is currently the only consumer product which allows both
quantitative and qualitative measurements of a woman's personal LH
and human chorionic gonadotropin (hCG) hormone levels in a home
test, facilitating higher conception rates and early diagnosis of
issues with fertility hormones. The proposition of myLotus is to
help women conceive naturally.
Concepta has made significant progress recently, establishing
agreements with a number of distributors in China where myLotus has
been given cFDA approval. Concepta is initially targeting the
traditional route to market in China through Chinese hospitals and
plans to add the direct-to-consumer route in the near future.
The Company is also well on its way to achieving CE-marking and
commencing its direct-to-consumer launch in the UK and Europe in H1
2018. The Company has identified a significant global market
opportunity, with revenue potential of the Chinese and EU
unexplained infertility market estimated to be worth c.GBP600m per
annum.
Unexplained infertility refers to women that have been unable to
conceive after 6 months of trying. This highly motivated
target group of consumers won't typically be offered medical
intervention until 12 months of unsuccessfully trying, with IVF not
offered until two years. Research indicates couples start to take
positive action ahead of this time and there is little medical
support to help them do so.
About RNS Reach announcements
RNS Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases such as
marketing messages, corporate and product information into the
public domain. An RNS Regulatory announcement is required to be
notified under the AIM Rules for Companies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAFDPALXPEFF
(END) Dow Jones Newswires
March 29, 2018 02:02 ET (06:02 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024